Quinolinic acid is a key intermediate in the kynurenine pathway, the primary route by which the amino acid tryptophan is metabolized into nicotinamide adenine dinucleotide (NAD+)—a molecule essential for cellular energy, mitochondrial function, and redox balance. Although it plays an important physiological role as a precursor for NAD+ synthesis, quinolinic acid can become neurotoxic when produced in excess, contributing to oxidative stress, inflammation, and excitatory neurochemical imbalances. On the Neurotransmitter XL panel, quinolinic acid serves as a sensitive biomarker of chronic stress, immune activation, mitochondrial dysfunction, and neuroinflammation. When tryptophan metabolism is shifted toward the kynurenine pathway—typically by inflammation or cortisol—quinolinic acid levels may rise. This metabolite’s dual nature makes it both vital and potentially harmful: necessary for energy metabolism but detrimental when uncontrolled.